NCT03581708

Venous Thromboembolism in Advanced Lung Cancer

Real-world Study of the Incidence and Risk Factors of Venous Thromboembolism (VTE) in Chinese Advanced Stage Lung Cancer

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 1,400 (estimated)
• Sponsor: Guangdong Provincial People's Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective observatory clinical study, aiming to establish and validate venous thromboembolism risk model in Chinese advanced non-small cell lung cancer.

Detailed description

VTE has high incidence in lung cancer and increases the mortality. Appropriate preventive measures contribute to 50% increase of incidence. The investigators are to investigate the VTE in advanced non-small cell lung cancer and delineate the risk factors to establish a VTE risk model system helping clinicians to differentiate VTE high risk population and apply early prevention in order to reduce the incidence of VTE.

Conditions

• Lung Neoplasms
• Venous Thromboembolism

Interventions

Type	Name	Description
OTHER	lung cancer	If the patient is diagnosed with lung cancer in advanced stage, he/she will be followed up for VTE incidence

Timeline

• Start date: 2018-07-01
• Primary completion: 2021-06-01
• Completion: 2022-06-01
• First posted: 2018-07-10
• Last updated: 2018-07-10

Locations

1 site across 1 country: China